Recommended by the Neural Network momentum algorithm. Top 10 pick, 10% portfolio weight. Position to be held for the first 3-week cycle of the fund until algo is run again and holdings updated.

Building initial portfolio based on momentum. Biogen has had a weak recent performance, signaling a good short opportunity based on our strategy.

This investment follows our S&P 500 without oil and gas companies momentum strategy. It's 3 month returns are bottom 10 in our shortlist, so we will take a short position on it.

Our investment strategy consists of buying the top 10 performing stocks of the Nasdaq 100 index, and short-selling the 10 worst-performing stocks of the same index. We chose the companies based on their performance in the last 3 months. Due to a holding period of only one month, we believe that a passive strategy is more appropriate than an active strategy. The weight of each company in our portfolio will be approximately equal, which increases diversification benefits of this portfolio. We will use almost all available debt in order to benefit from the additional expected returns from leverage.

With the new drug coming out in June and with Biogen at one of its lowest points in the stock market ever since the past year, I think this stock is gonna explode over the next few months

New experimental ALS medicine could be revolutionary